Amphotericin b cholesteryl sulfate Pregnancy and Breastfeeding Warnings
Amphotericin b cholesteryl sulfate is also known as: Amphotec
Amphotericin b cholesteryl sulfate Pregnancy Warnings
Amphotericin B cholesteryl sulfate has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Amphotericin B cholesteryl sulfate should be given during pregnancy only when benefit outweighs risk.
Amphotericin b cholesteryl sulfate Breastfeeding Warnings
There are no data on the excretion of amphotericin B cholesteryl sulfate into human milk. Due to the potential for serious adverse effects in a nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into consideration the importance of the drug to the woman.
See also
References for pregnancy information
- "Product Information. Amphotec (amphotericin B cholesteryl sulfate)." Sequus Pharmaceuticals Inc (2022):
- "Product Information. Ambisome (amphotericin B liposomal)" Nexstar Pharmaceuticals, San Dimas, CA.
References for breastfeeding information
- "Product Information. Amphotec (amphotericin B cholesteryl sulfate)." Sequus Pharmaceuticals Inc (2022):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.